14 results
10-Q
2022 Q3
PRME
Prime Medicine Inc
14 Nov 22
Quarterly report
4:46pm
Organization established a new advisory committee to create global governance and oversight standards for human gene editing. The Alliance for Regenerative … . In addition, we may seek a regenerative medicine advanced therapy, or RMAT, designation for some of our potential product candidates. An RMAT is defined
424B4
PRME
Prime Medicine Inc
21 Oct 22
Prospectus supplement with pricing info
4:47pm
governance and oversight standards for human gene editing. The Alliance for Regenerative Medicine also released principles for the use of gene … later decide that such product candidates no longer meet the conditions for qualification. In addition, we may seek a regenerative medicine advanced
S-1/A
z6x044do5l
13 Oct 22
IPO registration (amended)
10:51am
S-1
ifn0ls r0wojks
23 Sep 22
IPO registration
4:12pm
DRS/A
wcd1s4529iof1d 2tq
5 Aug 22
Draft registration statement (amended)
12:00am
DRS/A
n7a4udnq4zm1o
6 May 22
Draft registration statement (amended)
12:00am
DRS/A
e9lvb66wvrsmchgx0e3
8 Apr 22
Draft registration statement (amended)
12:00am
DRS/A
2k8fy
25 Mar 22
Draft registration statement (amended)
12:00am
DRS/A
cn16 7oud
7 Mar 22
Draft registration statement (amended)
12:00am
DRS/A
o2f45f4esnnu 600
4 Feb 22
Draft registration statement (amended)
12:00am
DRS
fi01nc1gtaufkgys35y
20 Dec 21
Draft registration statement
12:00am
- Prev
- 1
- Next